YU49492B - Lak za nokte koji deluje protiv psorijaze - Google Patents

Lak za nokte koji deluje protiv psorijaze

Info

Publication number
YU49492B
YU49492B YU34998A YU34998A YU49492B YU 49492 B YU49492 B YU 49492B YU 34998 A YU34998 A YU 34998A YU 34998 A YU34998 A YU 34998A YU 49492 B YU49492 B YU 49492B
Authority
YU
Yugoslavia
Prior art keywords
nail polish
works against
against psoriasis
psoriasis
glucocorticoids
Prior art date
Application number
YU34998A
Other languages
English (en)
Serbo-Croatian (sh)
Other versions
YU34998A (sh
Inventor
Manfred Bohn
Karl Theodor Kraemer
Original Assignee
Aventis Pharma Deutschland Gmbh.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland Gmbh. filed Critical Aventis Pharma Deutschland Gmbh.
Publication of YU34998A publication Critical patent/YU34998A/sh
Publication of YU49492B publication Critical patent/YU49492B/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A61Q3/02—Nail coatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Finger-Pressure Massage (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
YU34998A 1997-08-21 1998-08-19 Lak za nokte koji deluje protiv psorijaze YU49492B (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19736112 1997-08-21

Publications (2)

Publication Number Publication Date
YU34998A YU34998A (sh) 2002-11-15
YU49492B true YU49492B (sh) 2006-08-17

Family

ID=7839551

Family Applications (1)

Application Number Title Priority Date Filing Date
YU34998A YU49492B (sh) 1997-08-21 1998-08-19 Lak za nokte koji deluje protiv psorijaze

Country Status (35)

Country Link
US (3) US6352686B2 (enExample)
EP (1) EP0913154B1 (enExample)
JP (1) JPH11130679A (enExample)
KR (1) KR100610517B1 (enExample)
CN (1) CN1155386C (enExample)
AR (1) AR015933A1 (enExample)
AT (1) ATE227993T1 (enExample)
AU (1) AU740615B2 (enExample)
BG (1) BG63270B1 (enExample)
BR (1) BR9803756A (enExample)
CA (1) CA2245637C (enExample)
CO (1) CO4960649A1 (enExample)
CZ (1) CZ292344B6 (enExample)
DE (1) DE59806343D1 (enExample)
DK (1) DK0913154T3 (enExample)
ES (1) ES2186952T3 (enExample)
HR (1) HRP980458B1 (enExample)
HU (1) HUP9801898A3 (enExample)
ID (1) ID20731A (enExample)
IL (1) IL125854A (enExample)
MY (1) MY128558A (enExample)
NO (1) NO319391B1 (enExample)
NZ (1) NZ331443A (enExample)
PL (1) PL192342B1 (enExample)
PT (1) PT913154E (enExample)
RO (1) RO118174B1 (enExample)
RU (1) RU2210354C2 (enExample)
SG (1) SG68072A1 (enExample)
SI (1) SI0913154T1 (enExample)
SK (1) SK284218B6 (enExample)
TR (1) TR199801609A2 (enExample)
TW (1) TW590776B (enExample)
UA (1) UA51693C2 (enExample)
YU (1) YU49492B (enExample)
ZA (1) ZA987531B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO118174B1 (ro) * 1997-08-21 2003-03-28 Aventis Pharma Deutschland Gmbh Lac de unghii şi utilizarea acestuia
CN1281287C (zh) * 2001-01-09 2006-10-25 伊斯雷尔·德沃列茨基 治疗性成膜组合物及其治疗系统
FR2830449B1 (fr) * 2001-10-05 2004-04-23 Fabre Pierre Dermo Cosmetique Utilisation du tazarotene pour la preparation d'un vernis a ongles pour le traitement et/ou la prevention du psoriasis et un vernis a ongles le contenant
FR2835180B1 (fr) * 2002-01-30 2004-04-09 Fiabila Vernis a ongles multiphase
AU2002950506A0 (en) * 2002-07-31 2002-09-12 Soltec Research Pty Ltd Percutaneous delivery system
EP1854466A1 (en) * 2002-12-17 2007-11-14 Galderma Research & Development, S.N.C. Pharmaceutical composition comprising a combination of calcitriol and clobetasol propionate
FR2848454B1 (fr) * 2002-12-17 2007-03-30 Galderma Res & Dev Composition pharmaceutique comprenant une association de calcitriol et d'un corticosteroide
CA2505406A1 (en) * 2002-12-17 2004-07-01 Galderma Sa Pharmaceutical compositions comprising a combination of calcitriol and a clobetasol propionate
US7238533B1 (en) * 2003-07-22 2007-07-03 Ronald Legge Personal illicit drug detection method
FR2871699A1 (fr) * 2004-06-17 2005-12-23 Galderma Sa Composition de type emulsion inverse contenant du calcitrol et du 17-propionate de clobetasol, et ses utilisations en cosmetiques et en dermatologie
JP4608618B2 (ja) * 2004-07-02 2011-01-12 有限会社 エヌ・ピィ・アール ネイルアート用溶液
US20060062982A1 (en) * 2004-09-17 2006-03-23 Massachusetts Institute Of Technology Carbon-polymer electrochemical systems and methods of fabricating them using layer-by-layer technology
CA2498623A1 (en) * 2005-02-18 2006-08-18 Qlt Inc. Treatment of onychomycosis
FR2884419B1 (fr) * 2005-04-19 2007-06-22 Galderma Sa Composition de type solution filmogene comprenant de la vitamine d ou un de ses derives et un corticosteroide, et son utilisation en dermatologie
WO2006111426A1 (en) * 2005-04-19 2006-10-26 Galderma S.A. Composition of film-forming solution type, comprising vitamin d or a derivative thereof and a corticosteroid, and use thereof in dermatology
EP1888026A4 (en) 2005-05-27 2012-07-04 Taro Pharmaceuticals North America Inc STABLE LIQUID FORMULATION WITH DESOXIMETASON AND ISOPROPYLMYRISTATE WITH REDUCED OXIDIZED CONTAMINATION DURING LONG-TERM STORAGE
KR100803926B1 (ko) 2006-07-27 2008-02-15 주식회사 코리아나화장품 샌드프리 화장료 조성물
US20090317341A1 (en) * 2008-06-18 2009-12-24 Conopco, Inc., D/B/A Unilever Compositions for Lightening Skin Color
FR2937250B1 (fr) * 2008-10-21 2013-05-10 Fabre Pierre Dermo Cosmetique Solution filmogene a base d'uree pour le traitement du psorasis de l'ongle
EP2482822B1 (en) 2009-10-01 2018-08-01 Adare Pharmaceuticals, Inc. Orally administered corticosteroid compositions
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
TWI777515B (zh) 2016-08-18 2022-09-11 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法
PL233616B1 (pl) 2017-08-10 2019-11-29 Podopharm Spolka Z Ograniczona Odpowiedzialnoscia Preparat do paznokci, dloni i stop oraz sposob wytwarzania tego preparatu
EP4563161A1 (en) * 2022-07-28 2025-06-04 Kao Corporation Composition for external preparation

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928261A (en) * 1973-05-17 1975-12-23 Minnesota Mining & Mfg Water removable film-forming compositions for topical application to skin
US3861932A (en) * 1973-12-13 1975-01-21 Revlon Stabilization of nitrocellulose
US3966924A (en) * 1974-11-13 1976-06-29 Allergan Pharmaceuticals Composition and method for treating psoriasis
US4179304A (en) * 1978-04-03 1979-12-18 Polychrome Corporation Finger nail lacquer
US4210633A (en) * 1978-10-20 1980-07-01 Eli Lilly And Company Flurandrenolide film formulation
US4250164A (en) * 1979-04-09 1981-02-10 Bernstein Joel E Method of treating psoriasis of the nails and composition
DE3687458T2 (de) * 1985-11-04 1993-07-29 Owen Galderma Lab Inc Filmbildende arzneimitteltraeger zur verabreichung von arzneimitteln an naegeln
DE3544983A1 (de) * 1985-12-19 1987-06-25 Hoechst Ag Antimykotisch wirksamer nagellack
DE3612305A1 (de) * 1986-04-11 1987-10-22 Roehm Pharma Gmbh Fluessige arzneiform zur therapie der psoriasis auf basis filmbildender polymere
US5091171B2 (en) * 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
DE3720147A1 (de) * 1987-06-16 1988-12-29 Hoechst Ag Antimykotisch wirksamer nagellack sowie verfahren zu dessen herstellung
US5093108A (en) * 1989-02-16 1992-03-03 Amalia, Inc. Quick-drying nail enamel compositions and method for coating a surface
CA2008775C (en) * 1989-02-24 1998-12-22 Alberto Ferro Nail lacquer
US5258186A (en) * 1989-03-10 1993-11-02 Yamanouchi Pharmaceutical Co., Ltd. Drug release controlling coating material for long acting formulations
HU219480B (hu) * 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
DE19518262A1 (de) * 1995-05-18 1996-11-21 Hoechst Ag Die Verwendung von Glyceryltriacetat zur Behandlung von Onychomykosen
EP0711181A1 (en) * 1993-07-28 1996-05-15 Pfizer Inc. Psoriasis treatment
DK128494A (da) * 1994-11-08 1996-05-09 Edel K Seidenschnur Behandling af keratinøse og psoriatiske sygdomstilstande med neglelak indeholdende vitamin D metabolit, eller derivat, og/eller vitamin A derivat
DE19529085A1 (de) * 1995-08-08 1997-02-13 Christiane Dr Med Wurdel Nagellack zur Bekämpfung der Schuppenflechte im Nagelbereich
AU1876797A (en) * 1996-03-16 1997-10-10 Hoechst Aktiengesellschaft Topical formulations for the treatment of nail psoriasis
GB9609653D0 (en) 1996-05-09 1996-07-10 Applied Research Ars Holding N Method of assay
RO118174B1 (ro) * 1997-08-21 2003-03-28 Aventis Pharma Deutschland Gmbh Lac de unghii şi utilizarea acestuia

Also Published As

Publication number Publication date
TR199801609A3 (tr) 1999-03-22
HUP9801898A3 (en) 2000-01-28
ES2186952T3 (es) 2003-05-16
AU740615B2 (en) 2001-11-08
HRP980458B1 (en) 2002-12-31
NO983818D0 (no) 1998-08-20
CN1155386C (zh) 2004-06-30
IL125854A0 (en) 1999-04-11
TW590776B (en) 2004-06-11
CZ263298A3 (cs) 1999-03-17
YU34998A (sh) 2002-11-15
CO4960649A1 (es) 2000-09-25
CN1209318A (zh) 1999-03-03
BG102696A (bg) 1999-04-30
JPH11130679A (ja) 1999-05-18
HK1018214A1 (en) 1999-12-17
US20040071645A1 (en) 2004-04-15
US6352686B2 (en) 2002-03-05
CZ292344B6 (cs) 2003-09-17
RU2210354C2 (ru) 2003-08-20
KR100610517B1 (ko) 2007-04-25
CA2245637C (en) 2008-07-15
RO118174B1 (ro) 2003-03-28
NO983818L (no) 1999-02-22
ZA987531B (en) 1999-02-22
ATE227993T1 (de) 2002-12-15
PL192342B1 (pl) 2006-10-31
HRP980458A2 (en) 1999-06-30
NO319391B1 (no) 2005-08-08
DK0913154T3 (da) 2003-03-03
EP0913154A1 (de) 1999-05-06
CA2245637A1 (en) 1999-02-21
SK114398A3 (en) 1999-03-12
IL125854A (en) 2004-02-19
TR199801609A2 (xx) 1999-03-22
AR015933A1 (es) 2001-05-30
AU8085698A (en) 1999-03-04
EP0913154B1 (de) 2002-11-20
BG63270B1 (bg) 2001-08-31
DE59806343D1 (de) 2003-01-02
NZ331443A (en) 1999-01-28
BR9803756A (pt) 2000-03-28
KR19990023719A (ko) 1999-03-25
UA51693C2 (uk) 2002-12-16
SI0913154T1 (sl) 2003-04-30
PT913154E (pt) 2003-04-30
US20020071815A1 (en) 2002-06-13
ID20731A (id) 1999-02-25
SG68072A1 (en) 1999-10-19
MY128558A (en) 2007-02-28
US20010006625A1 (en) 2001-07-05
HUP9801898A1 (hu) 1999-04-28
SK284218B6 (en) 2004-11-03
HU9801898D0 (en) 1998-10-28
PL328122A1 (en) 1999-03-01

Similar Documents

Publication Publication Date Title
NO971192L (no) Fremgangsmåter for avlevering av materialer inn i huden, og sammensetninger som blir anvendt
NO20010757L (no) Spraybandasje og medikamentutleveringssystem
NO307206B1 (no) Preparater på basis av virkestoffer fra taxanklassen samt perfusjonspreparat inneholdende disse
MEP26508A (en) Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
ATE185548T1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
PE3995A1 (es) Composicion cosmetica que contiene pigmentos tratados en su superficie
DK0812198T3 (da) Stabilisering af prostaglandinpræparater
DE69738000D1 (de) Neue Arzneiformulierung enthaltend Budesonide
DE3481680D1 (de) Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung.
ES2124793T3 (es) Derivados de rapamicina alquilados en o y su uso, particularmente como inmunosupresores.
DK0539215T3 (da) Forøgelse af penetrationen af topisk anvendelige formuleringer
YU53098A (sh) Preparat koncentrovanog antitela
ATE271381T1 (de) Transdermale verabreichung basischer wirkstoffe unter verwendung unpolarer haftsysteme und saurer lösungsvermittler
IT8523141A0 (it) Pigmento organico perfezionato da impiegare in composizioni per lo sviluppo di immagini elettrostatiche latenti, metodo per la su preparazione e composizione liquida che utilizza il pigmento organico perfezionato.
ES2103198B1 (es) Nueva formulacion cosmetica y farmaceutica de antiandrogenos de origen natural (vegetal) para aplicacion topica percutanea.
PE20000028A1 (es) Aplicadores
DE69523086D1 (de) 1,4-Cyclohexan-Dimethanol enthaltende Beschichtungszusammensetzungen
FI935427A0 (fi) Haorlaeggningsmedel och -kompositioner, som innehaoller hydrofoba polymerer foer laeggning av haor
TR199700834T1 (xx) 1-Aril-2-Akilamino ethan bile�ikleri ve bunlar�n n�rokinin olarak �zellikle n�rokinin 1 has�mlar� olarak kullan�mlar�.
ECSP941120A (es) Derivados de 1,5 benzodiazepina
ES2180259T3 (es) Utilizacion de un ester de celulosa para disminuir el tiempo de secado de una composicion de esmalte de uñas que contiene nitrocelulosa.
MD777G2 (ro) Compoziţie pentru acoperirea suprafeţei ambalajului şi procedeu de obţinere a acesteia
BR9806193A (pt) Composição bi-aromáticos ligados por um radical heteroetinileno e composições farmacêuticas e cosméticas que os contêm
IT1254549B (it) Prodotti vernicianti all'acqua, bicomponenti, a base acrilica-poliuretanica.
MX9307203A (es) COMPUESTOS ESTEROIDALES DE ACIL-3-CARBOXI-3,5-DIENO-17Ó Y 17ß -SUBSTITUIDOS.